147 related articles for article (PubMed ID: 33515629)
1. SkinSerious: Disseminated intravascular coagulation complicating Stevens-Johnson syndrome and toxic epidermal necrolysis.
Heymann WR
J Am Acad Dermatol; 2021 Apr; 84(4):911-912. PubMed ID: 33515629
[No Abstract] [Full Text] [Related]
2. Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chen CB; Hsu TH; Chung-Yee Hui R; Lu CW; Chen WT; Chiang PH; Wang CW; Chuang SS; Yang JY; Yang SY; Chang SY; Hsiao YC; Kao KC; Hu HC; Wu TS; Hsu CW; Hui-Kang Ma D; Chen SY; Tian YC; Cheng CY; Chen CH; Chi MH; Wu MY; Liu RF; Wang CH; Chang YC; Lin JY; Ho HC; Yu-Wei Lin Y; Chang CJ; Lin YJ; Ku CL; Hung SI; Chung WH;
J Am Acad Dermatol; 2021 Jun; 84(6):1782-1791. PubMed ID: 32828861
[TBL] [Abstract][Full Text] [Related]
3. Disseminated intravascular coagulation associated with toxic epidermal necrolysis (Lyell's syndrome).
Kvasnicka J; Rezác J; Svejda J; Duchková H; Kaze F; Zalud P; Richter J
Br J Dermatol; 1979 May; 100(5):551-8. PubMed ID: 444427
[TBL] [Abstract][Full Text] [Related]
4. [Disseminated intravascular coagulation in skin diseases].
Płatek-Twardoch C
Przegl Dermatol; 1984; 71(6):609-14. PubMed ID: 6399129
[No Abstract] [Full Text] [Related]
5. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
[TBL] [Abstract][Full Text] [Related]
7. Disseminated intravascular coagulopathy: a complication of Stevens-Johnson syndrome/toxic epidermal necrolysis.
El-Azhary RA; Nowsheen S; Gibson LE; DiCaudo DJ
Int J Dermatol; 2021 Feb; 60(2):185-189. PubMed ID: 33332598
[TBL] [Abstract][Full Text] [Related]
8. Asplenic fulminant sepsis secondary to a dog bite complicated by toxic epidermal necrolysis/Stevens-Johnson syndrome.
Teo KG; Anavekar NS; Yazdabadi A; Ricketts S
N Z Med J; 2012 Jul; 125(1358):74-7. PubMed ID: 22864159
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
[TBL] [Abstract][Full Text] [Related]
10. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
11. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
12. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
13. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.
Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W
Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
[TBL] [Abstract][Full Text] [Related]
17. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
Assaad D; From L; Ricciatti D; Shapero H
Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
20. Fatal case of toxic epidermal necrolysis caused by cefozopran and associated with psoriasis.
Sawada Y; Kabashima-Kubo R; Hino R; Nakamura M
Acta Derm Venereol; 2014 May; 94(3):341-2. PubMed ID: 24048229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
